S

Sanofi Ventures

10 employees

Sanofi Ventures operates as the corporate venture capital arm of Sanofi.

Investor insights

Sectors invested in

Biotechnology55
Health Care40
Therapeutics30
Medical29
Pharmaceutical27
Biopharma7
Life Science6
Cystic Fibrosis5
Clinical Trials5
Digital Health5
Genetics4
Medical Device4
Digital Therapeutics4
RNA Therapies3
Non-Viral Lipid Nanoparticles3
Genetic Medicines3
Genetic Respiratory Disease3
Primary Ciliary Dyskinesia3
Mobile Nursing3
Telemedicine3

Funding rounds participated in

$45M sweet spot round size

Most of their 69 investments are in rounds between $23M and $67M

Investor type

Corporate Venture Capital

Basic info

Sectors

Biotechnology
Financial Services
Health Care

Date founded

2001

Investments made

R

ReCode Therapeutics raised $50M on September 19, 2023

Investors: OrbiMed Advisors, Solasta Ventures, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP), MPM Capital and Sanofi Ventures

R

ROME Therapeutics raised $72M on September 12, 2023

Investors: Bristol-Myers Squibb, UK, GV, Section 32, Casdin Capital, LLC and Sanofi Ventures

V

VERALOX Therapeutics raised $24M on June 20, 2023

Investors: JDRF T1D Fund, Genesys Capital, Pappas Capital, NYBC Ventures and Sanofi Ventures

T

Therini Bio, Inc. (formerly MedaRed, Inc.) raised $36M on April 27, 2023

Investors: The Dementia Discovery Fund, SV Life Sciences, Dolby Family Ventures and Sanofi Ventures

Q

QurAlis raised $88M on March 9, 2023

Investors: Life Sciences Partners (LSP), MP Healthcare Venture Management Inc, Mission Bay Capital, EQT Life Sciences, Mission BioCapital, Inkef and Sanofi Ventures

A

Avilar Therapeutics raised $15M on February 16, 2023

Investors: Astellas Venture Capital L.L.C., RA Capital Management, L.P., Medical Excellence Capital, LLC and Sanofi Ventures

N

NextPoint Therapeutics, Inc. raised $80M on January 10, 2023

Investors: Catalio Capital Management, Sixty Degree Capital, Leaps by Bayer, MPM Capital, The Invus Group and Sanofi Ventures

U

Undisclosed raised $23M on December 15, 2022

Investors: Pureos Bioventures, REPAIR Impact Fund, Adjuvant Capital, Industrifonden, Wellington Partners, Sunstone Life Science Ventures, Trill Impact and Sanofi Ventures

E

Escient Pharmaceuticals raised $120M on November 28, 2022

Investors: Osage University Partners (OUP), Redmile Group, The Column Group, Avego Healthcare Capital, The Eleven Fund, Partner Fund Management and Sanofi Ventures

N

Normunity raised $65M on October 25, 2022

Investors: Osage University Partners (OUP), Canaan and Sanofi Ventures

FAQ